Spinal muscular atrophy--recent therapeutic advances for an old challenge. (Q38489298)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986506%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

review article

1 reference

title

Spinal muscular atrophy--recent therapeutic advances for an old challenge (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986506%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

main subject

spinal muscular atrophy

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986506%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Monica Nizzardo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986506%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Giacomo P Comi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986506%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Stefania Corti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986506%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Irene Faravelli

1

1 reference

3 September 2017

Monica Nizzardo

2

1 reference

3 September 2017

Giacomo P Comi

3

1 reference

3 September 2017

Stefania Corti

4

1 reference

3 September 2017

language of work or name

English

0 references

publication date

19 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986506%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

published in

Nature Reviews Neurology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986506%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986506%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986506%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

351-359

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25986506%20AND%20SRC:MED&resulttype=core&format=json

Two early infantile hereditary cases of progressive muscular atrophy simulating dystrophy, but on a neural basis. 1891.

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Spinal muscular atrophy: diagnosis and management in a new therapeutic era

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Phenotypic and molecular insights into spinal muscular atrophy due to mutations in BICD2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Observational study of spinal muscular atrophy type I and implications for clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Childhood spinal muscular atrophy: controversies and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Consensus Statement for Standard of Care in Spinal Muscular Atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Cardiac defects contribute to the pathology of spinal muscular atrophy models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Congenital heart disease is a feature of severe infantile spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Modern management of spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Bone health and associated metabolic complications in neuromuscular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Sleep architecture in infants with spinal muscular atrophy type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Clinical characteristics of three subtypes of spinal muscular atrophy in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

A natural history study of late onset spinal muscular atrophy types 3b and 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

21 January 2018

Spinal muscular atrophy

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Identification and characterization of a spinal muscular atrophy-determining gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Genetic testing and risk assessment for spinal muscular atrophy (SMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Cystic fibrosis newborn screening: a model for neuromuscular disease screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

SMN-targeted therapeutics for spinal muscular atrophy: are we SMArt enough yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

NeuroNEXT SMA biomarkers study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Spinal muscular atrophy: therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Regulation of SMN protein stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Early heart failure in the SMNDelta7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

A novel method for oral delivery of drug compounds to the neonatal SMNDelta7 mouse model of spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

RETRACTED ARTICLE: Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug-like compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Induced pluripotent stem cells from a spinal muscular atrophy patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Refined characterization of the expression and stability of the SMN gene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

A cell system with targeted disruption of the SMN gene: functional conservation of the SMN protein and dependence of Gemin2 on SMN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Chaperoning ribonucleoprotein biogenesis in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

An assembly chaperone collaborates with the SMN complex to generate spliceosomal SnRNPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

The SMN complex: an assembly machine for RNPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Molecular functions of the SMN complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Impaired minor tri-snRNP assembly generates differential splicing defects of U12-type introns in lymphoblasts derived from a type I SMA patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Essential role for the SMN complex in the specificity of snRNP assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

SMN control of RNP assembly: from post-transcriptional gene regulation to motor neuron disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Requirement of enhanced Survival Motoneuron protein imposed during neuromuscular junction maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

HuD interacts with survival motor neuron protein and can rescue spinal muscular atrophy-like neuronal defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

At the "junction" of spinal muscular atrophy pathogenesis: the role of neuromuscular junction dysfunction in SMA disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Skeletal muscle DNA damage precedes spinal motor neuron DNA damage in a mouse model of Spinal Muscular Atrophy (SMA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Early onset muscle weakness and disruption of muscle proteins in mouse models of spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

SMN-dependent intrinsic defects in Schwann cells in mouse models of spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

SMN is required for sensory-motor circuit function in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

A positive modifier of spinal muscular atrophy in the SMN2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Assays for the identification and prioritization of drug candidates for spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

SMN-inducing compounds for the treatment of spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

A placebo-controlled trial of gabapentin in spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

How genetic modifiers influence the phenotype of spinal muscular atrophy and suggest future therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Natural history of denervation in SMA: relation to age, SMN2 copy number, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Systemic delivery of scAAV9 expressing SMN prolongs survival in a model of spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

A large animal model of spinal muscular atrophy and correction of phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA: a dose-response study in mice and nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

The AAV vector toolkit: poised at the clinical crossroads

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Oligonucleotide-mediated survival of motor neuron protein expression in CNS improves phenotype in a mouse model of spinal muscular atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

A short antisense oligonucleotide ameliorates symptoms of severe mouse models of spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Improved antisense oligonucleotide design to suppress aberrant SMN2 gene transcript processing: towards a treatment for spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

A novel morpholino oligomer targeting ISS-N1 improves rescue of severe spinal muscular atrophy transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Morpholino antisense oligonucleotides targeting intronic repressor Element1 improve phenotype in SMA mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

A screen for regulators of survival of motor neuron protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Tetracyclines that promote SMN2 exon 7 splicing as therapeutics for spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Motor neuron disease. SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Non-5q spinal muscular atrophies: the alphanumeric soup thickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Newborn and carrier screening for spinal muscular atrophy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

International SMA consortium meeting. (26-28 June 1992, Bonn, Germany)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Early laparoscopic fundoplication and gastrostomy in infants with spinal muscular atrophy type I

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Technical standards and guidelines for spinal muscular atrophy testing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Clinical utility gene card for: proximal spinal muscular atrophy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

The high frequency of genetic diseases in hypotonic infants referred by neuropediatrics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Spinal muscular atrophy: the RNP connection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Effect of Combined Systemic and Local Morpholino Treatment on the Spinal Muscular Atrophy Δ7 Mouse Model Phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.77

Spinal muscular atrophy and a model for survival of motor neuron protein function in axonal ribonucleoprotein complexes

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25986506

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cardiac involvement in patients with spinal muscular atrophies.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25986506